Explore clinical trials for the treatment of chronic cough in patients with IPF and non-IPF ILDs
There are currently no FDA-approved treatments for IPF and non-IPF ILD-related chronic cough and current antifibrotics have failed to show a benefit in cough reduction.
Clinical trials are an important part of advancing the understanding and potential management of chronic cough in patients living with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung diseases (non-IPF ILDs).
Clinical Trials at a Glance
What is a clinical trial?
Clinical trials are medical research to learn more about how a potential new medication, or an existing medication works. The research helps to answer important questions on its effectiveness and its safety. All medications must undergo testing and obtain regulatory approval or authorization before they can be prescribed.
Why is it important to participate in clinical trials?
Clinical trials can only take place when patients choose to participate.
Examples of reasons patients choose to join clinical trials include:
- To play a more active role in their own health care
- To gain deeper understanding about their disease
- To help find new or better treatments
Find a Chronic Cough Clinical Trial
You can explore recruiting clinical trials for chronic cough in patients with IPF and non-IPF ILDs using publicly available databases.
The button link includes filters for:
- Conditions: idiopathic pulmonary fibrosis, interstitial lung disease, pulmonary fibrosis
- Keyword: cough
- Location: United States
- Study status: Not yet recruiting and Recruiting
This is intended to help identify studies that may be relevant.
This information is provided for educational purposes only. The studies listed are not endorsed by Trevi Therapeutics.
Patients should speak with their healthcare provider to determine whether participation in a clinical trial may be appropriate for them.